Loading company financials…
NASDAQ NMS - GLOBAL MARKET · Financial Services · CIK 0001527166
$39.20
+5.18% · delayed ~15 min
Last price from Oct 22, 2026
$14.01B market value
From Carlyle Group Inc.'s FY2025 10-K, filed Feb 27, 2026 · read the filing
Carlyle trades securities and runs financial markets. It took in $4.78B last year, which makes it a mid-sized company. Of every dollar it sells, about 17 cents is left as profit.
The financial picture is mixed, with profitability and debt needing attention and growth weaker.
A conclusion from the filings, not a recommendation. Detailed figures and supporting evidence appear in their dedicated sections below.
Recent open-market selling by Rubenstein David M., not under a pre-arranged plan.
$17.1M sold in the last 120 days · Read the filing
These are things the company filed or that a published model flagged — not predictions, and not a reason on their own to buy or sell anything.
Financial health
A mixed picture — some clear strengths and some weaknesses.
From Carlyle Group Inc.'s FY2025 annual filing · share price scored separately
Largest year-over-year changes in FY2025
Free cash flow
-$837.2M → -$3.37B
Cash
$1.27B → $1.97B
Profit
$1.02B → $808.7M
Earnings per share
$2.86 → $2.26
Measured against FY2024, from the 10-K filed Feb 27, 2026
Deteriorated: $2.54B wider
-$837.2M to -$3.37BCritical
Why it matters: Cash left after paying for the plant that produced it — the money genuinely available for dividends, buybacks or paying down debt. Harder to flatter than profit.
How the latest move compares (quote delayed ~15 min), and what was published around it
CG rose 5.18% on the latest quote. The average Financials company tracked here moved +1.11%, and the S&P 500 −1.04%. That is 4.1 points above its sector and 6.2 points above the market.
No filing from CG and no news item about it appeared in the last 3 days.
These coincide with the move in time. None is presented as its cause: a price can move on news that names no company, on the wider market, or on trading that no document records.
Filter by minute, hour, day or week — or compare against peers
Loading price history…
Expectations
Not from the filings — what other people are betting on, and what the price already assumes.
Opinions from 28 analysts covering this company, as of . Their views, not this site's.
Of 28 analysts publishing on this company, 4 say strong buy, 12 say buy, 11 say hold and 1 say sell. Analysts are paid to publish a view and are wrong often; the split above says how much they agree with each other, which is the part a single headline rating hides.
Published by Finnhub. Analyst coverage skews towards larger companies and towards optimism — sell ratings are rare across the whole market, so a company with none is ordinary rather than endorsed.
The essentials
Each answered from the filings, with the numbers behind it.
Yes. It keeps about 17 cents of every dollar of sales as profit, earning $808.7M last year. Note that operations still consumed cash despite the reported profit.
No. Sales shrank 11.9% last year.
For every $1 it owes, it owns $1.32 in assets. Banks and insurers always carry high debt — that is how lending works — so this is normal for the industry and not comparable with other sectors.
Core operating and valuation reference metrics
Whether the dividend is covered by what the business actually earns
It pays out 62 cents of every dollar of profit and keeps the rest, which leaves the payment comfortably covered. It has paid in each of the last 12 years.
GoodNext payment expected around , projected from how regularly it has paid before rather than from a date the company has announced.
Figures from the FY2025 annual filing
Last year it earned $808.7M and generated -$3.28B of cash from operations.
As reported to the SEC, in USD. Hover or show sources to see where each figure came from.
| Income statement | FY202510-K · Feb 27, 2026Filing for FY2025 | FY202410-K · Feb 27, 2025Filing for FY2024 | FY202310-K · Feb 22, 2024Filing for FY2023 | FY202210-K · Feb 9, 2023Filing for FY2022 | FY202110-K · Feb 10, 2022Filing for FY2021 | ChangeFY2025 vs FY2024 |
|---|---|---|---|---|---|---|
| RevenueWhat is this? | $4.78B | $5.43B | $2.96B | $4.44B | $8.78B | −11.9% |
| Selling, general and administrative | — | — | — | $575.8M | $431.7M | — |
| Interest expense | $123.9M | $121.0M | $123.8M | $110.4M | $113.3M | +2.4% |
| Income before tax | $1.16B | $1.39B | -$600.9M | $1.57B | $4.03B | −16.8% |
| Net income | $808.7M | $1.02B | -$608.4M | $1.23B | $2.97B | −20.7% |
| Net marginNet income ÷ revenueWhat is this? | 16.9% | 18.8% | -20.5% | 27.6% | 33.9% | −1.9 pts |
| Earnings per shareNet income ÷ shares outstanding at the period end — close to, but not the same as, the reported EPSWhat is this? | $2.26 | $2.86 | $-1.68 | $3.38 | $8.37 | −20.8% |
† calculated from other reported figures, such as total liabilities as assets minus equity.
This company's latest filing beside its peers' stored scores
| Company | Health | F-Score | Revenue growth | Profit margin | P/E | Debt to equity |
|---|---|---|---|---|---|---|
| CGCarlyle Group Inc. · this page | 4.7/10 | 2/6 |
Insider activity, ownership stakes and what's coming — straight from EDGAR, before any article is written about it
Officers, directors and major shareholders must report within two business days of a trade.
Gifted shares — 100,000 shares
Holds 27,299,644 shares after this filing.
Sold on the open market — 400,000 shares at $42.74 ($17.1M)
Holds 26,899,644 shares after this filing.
20 recent filings, newest first. Each is labelled from its form and item numbers, not from its wording.
Quarterly report for Q2 FY2026
Revenue -28.6% · Profit margin −8.1 pts · Profit -57.1% — against Q2 FY2025
Read the filingPublished results
Read the filingWrite down why you are following Carlyle Group Inc., what has to go right and what would change your mind, then see each new annual report measured against it. Sign in to start one.
Go deeper
Every figure above traces back to a filing in the timeline, each linked to the document itself.
The 1,230 subsidiaries named in its 10-K, incorporated across 34 places. A filer lists the significant ones and may leave the rest out, so this is the floor rather than the full count.
Every company's figures are checked for internal consistency: the balance sheet adding up, figures sharing one currency, cash flow and share counts within plausible ranges, and how recent the latest annual report is. Nothing here changes a figure.
Financial figures are from CG's 10-K for fiscal year 2025 (period ending 2025-12-31, filed Feb 27, 2026), reported under the US GAAP taxonomy. View the source filing.
3 of 4 scored areas had enough reported figures to judge
The score averages profitability, growth, debt and accounting. Accounting had too few reported figures and is left out of the average rather than counted as a weakness, so a company is never marked down for a figure it did not publish. Cash generation is shown for context and already feeds profitability. Valuation is scored separately, because a share price says nothing about whether the business is sound. 6 of the 9 Piotroski checks could be evaluated. How the score works
Each year scored only from its annual report as it was first filed
| Fiscal year | Health | F-Score | Scored from |
|---|---|---|---|
| FY2025 | 4.7 | 2/6 | 10-K, filed Feb 27, 2026 |
| FY2024 | 7.3 | 4/6 | 10-K, filed Feb 27, 2025 |
| FY2023 | 3.3 | 3/6 | 10-K, filed Feb 22, 2024 |
| FY2022 | 4.7 | 2/6 | 10-K, filed Feb 9, 2023 |
| FY2021 | 8.7 | 5/6 | 10-K, filed Feb 10, 2022 |
| FY2020 | 4.7 | 1/6 | 10-K, filed Feb 11, 2021 |
A later restatement never reaches back into an earlier year, and every year is scored without a share price, so the latest point can differ a little from the headline score, which uses today's price.
Every check behind the three models, and what each one tests
2 of 6 checks passed
Nine yes-or-no tests of whether this year's finances improved on last year's. 3 could not be evaluated and are excluded from the total rather than counted as failures.
not reported — Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
Distance from bankruptcy, from a model fitted on companies that did and did not go bust. It describes a balance sheet's shape today; it does not forecast a failure.
not reported — Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
Screens eight accounting ratios for the pattern earnings manipulators tend to leave. A flag is a reason to read the filing closely, never evidence of wrongdoing.
Every figure above comes from the FY2025 filing as filed with the SEC.
Improved: +55.6%
$1.27B to $1.97BCritical
Why it matters: A falling cash pile is only a warning if the company is consuming it. Paying down debt, buying back stock and paying a dividend all reduce cash by choice.
Deteriorated: -20.7%
$1.02B to $808.7MSignificant
Why it matters: Profit swings far more than sales do, and one-off items — a legal settlement, a tax charge, an asset sale — move it without the underlying business changing.
Deteriorated: -20.8%
$2.86 to $2.26Significant
Why it matters: Profit divided by the shares in issue at the period end, so it sits close to but not on the company's own reported figure. It can rise with no growth in profit when the company buys back stock — read it beside the share count.
Changed: +27.9%
$77.7M to $99.4MSignificant
Why it matters: Neither good nor bad on its own. Heavy spending is a company building capacity or a company struggling to stand still, and the two look identical in this figure.
Deteriorated: -11.9%
$5.43B to $4.78BNotable
Why it matters: Sales are what everything else is built on. A fall can be lost customers, lower prices, or a business the company sold — the filing itself says which.
Deteriorated: −1.9 pts
18.8% to 16.9%Notable
Why it matters: What survives to the very end of each sale. Worth reading beside revenue: growing sales on a shrinking margin means the company is buying its growth.
Q2 FY2026 against Q2 FY2025, from the 10-Q filed Aug 10, 2026 — read it.
Deteriorated: -57.1%
$319.7M to $137.1MCritical
Why it matters: Profit swings far more than sales do, and one-off items — a legal settlement, a tax charge, an asset sale — move it without the underlying business changing.
Deteriorated: −8.1 pts
20.3% to 12.2%Critical
Why it matters: What survives to the very end of each sale. Worth reading beside revenue: growing sales on a shrinking margin means the company is buying its growth.
Deteriorated: -56.4%
$0.89 to $0.39Critical
Why it matters: Profit divided by the shares in issue at the period end, so it sits close to but not on the company's own reported figure. It can rise with no growth in profit when the company buys back stock — read it beside the share count.
Deteriorated: -28.6%
$1.57B to $1.12BSignificant
Why it matters: Sales are what everything else is built on. A fall can be lost customers, lower prices, or a business the company sold — the filing itself says which.
Improved: -1.6%
359.0M to 353.4MNotable
Why it matters: The company bought back stock, so each remaining holding owns slightly more of it. Worth checking it was not funded by borrowing.
Q2 FY2026 against Q1 FY2026, from the 10-Q filed Aug 10, 2026 — read it. Quarter-to-quarter moves include seasonal swings — a retailer's holiday quarter — which the year-earlier comparison removes.
Improved: +342.3%
$254.0M to $1.12BCritical
Why it matters: Sales are what everything else is built on. A fall can be lost customers, lower prices, or a business the company sold — the filing itself says which.
Improved: turned positive
-$132.2M to $137.1MCritical
Why it matters: Profit swings far more than sales do, and one-off items — a legal settlement, a tax charge, an asset sale — move it without the underlying business changing.
Improved: +64.3 pts
-52.0% to 12.2%Critical
Why it matters: What survives to the very end of each sale. Worth reading beside revenue: growing sales on a shrinking margin means the company is buying its growth.
Improved: turned positive
-$0.37 to $0.39Critical
Why it matters: Profit divided by the shares in issue at the period end, so it sits close to but not on the company's own reported figure. It can rise with no growth in profit when the company buys back stock — read it beside the share count.
Deteriorated: -24.9%
$1.67B to $1.26BSignificant
Why it matters: A falling cash pile is only a warning if the company is consuming it. Paying down debt, buying back stock and paying a dividend all reduce cash by choice.
Improved: -1.8%
359.8M to 353.4MNotable
Why it matters: The company bought back stock, so each remaining holding owns slightly more of it. Worth checking it was not funded by borrowing.
2 other measures barely moved. Figures compare the two most recent annual filings — read the latest one. Moves are graded on fixed lines — 5%, 15% and 40% for amounts, and 1, 3 and 8 points for margins — as notable, significant or critical. Nothing here reads the management commentary, which is where a company explains its own numbers.
Measured on and published about a week later — this is a fortnightly snapshot, not a live position.
About 6.2% of this company's shares have been borrowed and sold by people expecting to buy them back cheaper. That is a bet the price falls. Those people can be wrong, and when a heavily shorted share rises they have to buy it back, which pushes it up further.
Collected by FINRA from broker-dealers twice a month. It counts positions, not intentions, and some of it is hedging rather than a directional bet against the company.
Nothing in this section is a figure this company reported about itself. These are expectations and positions — what the price implies, what analysts have published, what short sellers are betting, and what large funds held at the last count. WylthIQ reports them; it does not endorse them, does not forecast prices, and takes no view on whether any of them will turn out to be right.
The trailing P/E is 43.0x — a high multiple relative to the current trailing profit.
Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
Reported annual figures
| -11.9% |
| 16.9% |
| 17.32x |
| 3.13x |
| TROWPRICE T ROWE GROUP INC | 7.3/10 | 3/6 | 3.1% | 28.5% | 10.83x | 0.21x |
|---|
| BENFRANKLIN TEMPLETON INC | 6.0/10 | 7/7 | 3.5% | 6.0% | 31.28x | 1.51x |
|---|
| IVZInvesco Ltd. | 3.3/10 | 4/7 | 5.1% | -2.7% | — | 1.15x |
|---|
| Median of peers | 6.0/10 | — | 3.5% | 6.0% | 21.06x | 1.15x |
|---|
Peers come from the company's industry classification. A difference describes the companies; it does not rank them.
Was granted or awarded shares — 2,657 shares
Holds 700,578 shares after this filing.
Was granted or awarded shares — 19,240 shares
Holds 5,273,362 shares after this filing.
Was granted or awarded shares — 8,302 shares
Holds 1,752,000 shares after this filing.
Was granted or awarded shares — 3,769 shares
Holds 852,461 shares after this filing.
Was granted or awarded shares — 304 shares
Holds 135,668 shares after this filing.
Was granted or awarded shares — 78 shares
Holds 11,109 shares after this filing.
Was granted or awarded shares — 6,615 shares
Holds 1,609,479 shares after this filing.
Notice filed ahead of a planned sale — the sale itself has not necessarily happened yet.
Filed notice to sell 400,000 shares ($17.2M) on or after .
Shares originally obtained via Shares received upon exchange of Carlyle Holdings partnership units on a one for one basis in connection with the conversion of the Issuer's predecessor entity to a corporation..
Estimated from how often this has happened before, not a confirmed date.
Not investment advice, and not a signal to act on by itself — a filing says what happened, not why, and insiders trade for ordinary reasons having nothing to do with where they think the company is headed.
Had a director or senior officer leave or join · Held a shareholder vote
Had a director or senior officer leave or join · Made a Regulation FD disclosure
Read the filingQuarterly report for Q1 FY2026
Revenue -73.9% · Profit margin −65.4 pts · Profit turned negative — against Q1 FY2025
Read the filingPublished results
Read the filingProxy statement for a shareholder meeting
Read the filingAnnual report for FY2025
Revenue -11.9% · Profit margin −1.9 pts · Free cash flow $2.54B wider — against FY2024
Read the filingMade a Regulation FD disclosure
Read the filingPublished results
Read the filingHad a director or senior officer leave or join · Made a Regulation FD disclosure
Read the filingQuarterly report for Q3 FY2025
Revenue -87.4% · Profit margin −22.3 pts · Profit -99.8% — against Q3 FY2024
Read the filingPublished results
Read the filingSigned a material agreement · Took on a direct financial obligation · Reported another event
Read the filingReported another event
Read the filingQuarterly report for Q2 FY2025
Revenue +47.0% · Profit margin +6.5 pts · Profit +115.7% — against Q2 FY2024
Read the filingPublished results
Read the filingHad a director or senior officer leave or join · Made a Regulation FD disclosure
Read the filingSigned a material agreement · Took on a direct financial obligation · Held a shareholder vote
Read the filingQuarterly report for Q1 FY2025
Revenue +41.4% · Profit margin +3.8 pts · Profit +98.2% — against Q1 FY2024
Read the filingThe first 40 of 1,230. The rest are in the exhibit.
Source: Exhibit 21 of the 10-K filed 2026-02-27. These are legal entities, not brands or acquisitions — a company that bought a business may hold it inside an entity named here, or inside one small enough that the rule does not require naming it at all.
Coverage from the last 30 days
Piper Sandler Maintains Overweight on Carlyle Group, Lowers Price Target to $48
Benzinga ·
Carlyle Secured Lending, Inc. Schedules Earnings Release and Quarterly Earnings Call to Discuss its Financial Results for the Third Quarter Ended September 30, 2026
Yahoo ·
New Private-Equity Firm Specializes in Giving Companies AI Glow-Ups
Yahoo ·
Nubank, Carlyle, StepStone Group, Cohen & Steers, and Houlihan Lokey Shares Plummet, What You Need To Know
Yahoo ·
UBS Maintains Buy on Carlyle Group, Lowers Price Target to $60
Benzinga ·
Carlyle Warns Private Credit Could Get Too Deep Into AI as $1 Trillion Financing Wave Looms
Benzinga ·
Hamilton Lane Makes Strategic Investment In Republic To Expand Retail Access To Private Markets
Benzinga ·
TD Cowen Maintains Hold on Carlyle Group, Lowers Price Target to $42
Benzinga ·
Sector Update: Financial Stocks Advance Friday Afternoon
Yahoo ·
3 Stocks Riding Gulf Money Into AI And Private Markets
Yahoo ·
'Carlyle Says Deal to Buy Lukoil International Assets Has Expired'- Bloomberg
Benzinga ·
Barclays Maintains Overweight on Carlyle Group, Lowers Price Target to $53
Benzinga ·
Primary sources and further research